Organic compounds -- part of the class 532-570 series February patents and inventions 02/08

20080051575 - Photochromic compounds: Various non-limiting embodiments disclosed herein relate generally to photochromic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. Other non-limiting embodiments relate to photochromic-dichroic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. For example, one non-limiting embodiment provides a thermally reversible,... Agent: Deborah M. Altman Ppg Industries, Inc.

20080051576 - Pigment for charge generating layer in photoreceptive device: Use of pigments for charge generating layers of imaging members. The pigments may include methoxygallium phthalocyanine. The pigments may have a sensitivity of between about 260 and about 290, and may include methoxygallium phthalocyanine that has been converted. The pigments may be used in a charge generating layer of an... Agent: Pillsbury Winthrop Shaw Pittman, LLP Xerox Corporation

20080051577 - Cross-linked glycopeptide-cephalosporin antibiotics: This invention provides cross-linked glycopeptide-cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.... Agent: Theravance, Inc.

20080051578 - Substituted biaryls, process for their manufacture and use thereof as medicaments: i

20080045704 - Photochromic compounds: Various non-limiting embodiments disclosed herein relate generally to photochromic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. Other non-limiting embodiments relate to photochromic-dichroic compounds, which may be thermally reversible or non-thermally reversible, and articles made therefrom. For example, one non-limiting embodiment provides a thermally reversible,... Agent: Deborah M. Altman Ppg Industries, Inc.

20080045705 - production method: r

20080033164 - Oxypentafluorosulfate compositions and processes for making them: Novel compositions are provided containing a compound represented by the formula YOSF5 or ZOSF5, where: (a) Y is: (i) an organic cation other than (Me2N)3S+ or (ii) an inorganic cation, provided that when Y is the inorganic cation, the composition further includes a complexing agent; and (b) Z is C1-20... Agent: Air Products And Chemicals, Inc. Patent Department

20080033165 - [beta]-lactamyl vasopressin v1a antagonists and methods of use: Novel 2-(azetidin-2-on-1-yl) alkanedioic acid derivativies and 2-(azetidin-2-on-1-yl) alkoxyalkanoic acid derivativies are described for use in the treatment of disease states responsive to antagonism of the vasopressin V1a receptor.... Agent: Barnes & Thornburg LLP

20080033166 - Process for production of 3-alkenylcephem compounds: A process for preparing 7-amino-3-[(E/Z)-2-(4-methylthiazol-5-yl)vinyl]-3-cephem-4-carboxylic acid of the formula (1) and an alkali metal salt thereof, said acid and said salt being improved in the content of 7-amino-3-[(Z)-2-(4-methylthiazol-5-yl)vinyl]-3-cephem-4-carboxylic acid of the formula (2) or an alkali metal salt thereof, the process being characterized in that an aqueous solution of an... Agent: Kubovcik & Kubovcik

20080033167 - Compositions and methods for synthesizing heterocyclic therapeutic compounds: Methods for the synthesis of various novel substituted dipeptide derived nitrogen-containing heterocyclic compounds and their pharmaceutically acceptable salt derivatives are provided. The compounds of the invention are useful as medicaments for the treatment or prevention of disease in a mammal, for example a human. In particular the compounds are useful... Agent: Mccarter & English LLP Cityplace I

20080033168 - Process for regenerating catalyst for producing e-caprolactam and process for producing e-caprolactam: The present invention provides a process for regenerating a catalyst for producing e-caprolactam comprising the steps of adsorbing a silicon compound on a zeolite catalyst that had been used for a Beckmann rearrangement reaction of cyclohexanone oxime and contacting the catalyst with an aqueous solution containing a compound selected from... Agent: Foley And Lardner LLP Suite 500